MTOR and glioblastoma: Daniele et al. [270] (2015) demonstrated that a combined inhibition of Mdm2 and Mdm2 stimulating the AKT/mTOR pathway using inhibitors ISA27 and FC85, respectively, enhanced glioblastoma multiforme (GBM) cell apoptosis and differentiation of CSCs.